SIME Diagnostics is a clinical AI company developing rapid respiratory intensive care diagnostics for acute unmet needs. Their patented platform features a compact, cloud-connected device with reagent-free disposables designed for point-of-care use in intensive care units. The system predicts acute respiratory diseases within 15 minutes using routinely collected samples and proprietary AI analysis. The first product targets neonatal lung maturity (respiratory distress syndrome), with pipelines for chronic lung disease and adult acute respiratory distress. By providing objective, actionable insights at critical decision moments, SIME aims to improve triage, enable earlier treatment, reduce patient risk, and lower hospital costs.